Back to search

Netherlands· NL-f0e49d46aa1f

Provarivax, poeder en oplosmiddel voor suspensie voor injectie in een voorgevulde spuit

A varicella, live attenuated product containing levend verzwakt varicellavirusvaccin, stam oka geproduceerd in humaan diploïde cellijn mrc5, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BK01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedProvarivax, poeder en oplosmiddel voo…ATCJ07BK01REGISTER NO.NL-f0e49d46aa1fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Varicella, live attenuated is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BK01 (varicella, live attenuated), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Varicella, live attenuated · ATC J07BK01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVEND VERZWAKT VARICELLAVIRUSVACCIN, stam OKA geproduceerd in Humaan diploïde cellijn MRC5
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
J07BK01
ATC class
Varicella, live attenuated
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29215

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd9a8a57-d32f-46f2-aa20-96381f0ccc90
GET /v1/drugs/cd9a8a57-d32f-46f2-aa20-96381f0ccc90?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor suspensie voor injectie",
  "route": "Subcutaan gebruik, Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29215_smpc.pdf",
  "strength": null,
  "atc_label": "Varicella, Live Attenuated",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29215",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "GELATINE, GEHYDROLYSEERD, AFKOMSTIG VAN VARKEN",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "NATRIUMGLUTAMAAT 1-WATER (E 621)",
    "SACCHAROSE",
    "UREUM (E 927B)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "LEVEND VERZWAKT VARICELLAVIRUSVACCIN, stam OKA geproduceerd in Humaan diploïde cellijn MRC5"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29215.pdf",
  "authorised_at": "2004/03/18",
  "procedure_number": "IT/H/0114/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29215",
  "additional_monitoring": "N"
}

See everything about varicella, live attenuated.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.